Sarfez Pharmaceuticals
ApprovedSarfez Pharmaceuticals develops torsemide diuretics for edema, heart failure, and kidney disease, advancing effective treatments for better patient care.
Founded
2018
Focus
Drug Delivery
About
Sarfez Pharmaceuticals develops torsemide diuretics for edema, heart failure, and kidney disease, advancing effective treatments for better patient care.
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile